United States: Exploring The Amgen Genus Claims Headed To High Court - Kramer Levin Naftalis & Frankel LLP

Mondaq

16 Jan 2023 0 shares 1 views

United States: Exploring The Amgen Genus Claims Headed To High Court - Kramer Levin Naftalis & Frankel LLP

Mondaq

Published 16 Jan 2023

Head of Life Sciences Irena Royzman and associate Jeffrey Coleman authored a Law360 article titled "Exploring The Amgen Genus Claims Headed To High Court" on Jan. 10, 2023.

Full Article

United States: SCOTUS Case With Implications For Attorney-Client Privilege Between CIPOs And C-Suite - Kramer Levin Naftalis & Frankel LLP

The article examines how the U.S. Supreme Court may broaden confidentiality of communications containing dual-purpose legal and..

Mondaq 24 Jan 2023

United States: Exploring The Amgen Genus Claims Headed To High Court - Kramer Levin Naftalis & Frankel LLP

United States: Exploring The Amgen Genus Claims Headed To High Court - Kramer Levin Naftalis & Frankel LLP

You might like

Related news coverage

United States: SCOTUS Case With Implications For Attorney-Client Privilege Between CIPOs And C-Suite - Kramer Levin Naftalis & Frankel LLP

Advertisement